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Prevalence and serologic diagnostics in Denmark.
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DVM
•Organism Responsible for Q fever 
Rocky Mountain Laboratories, NIAID, NIH
DTU National Veterinary Institute
Denmark
2Q fever occupational disease
• Farmers and their families
• Abattoir workers 
• Veterinarians
• Laboratory staff
• Pregnant people
3Q fever reservoirs
4Tabel 1. Serologic tests for Coxiella burnetii from 1989-2004 
Blood samples submitted for The Veterinary Institute in connection with export.
Q fever
Cattle Sheep and goat
Tested by CFT Positive Tested by CFT Positive
1989 684 2 - -
1990 595 6 - -
1991 102 0 - -
1992 53 2 76 0
1993 14 0 10 0
1994 175 4 65 0
1995 348 4 - -
1996 735 0 - -
1997 814 11 - -
1998 473 6 - -
1999 837 30 - -
2000 396 7 - -
2001 6 0 - -
2002 337 0 - -
2003 225 8 - -
2004 105 7 - -
5Test methods used in Denmark
• Serologic tests:  ELISA (IDEXX and LSI kits), CFT, IFAT
• CFT: only for dog pig none ruminants   , , -  
• IFAT: human samples
• FISH :placenta, fetus, bone marrow (Tim Jensen et al. developed and 
published 2007)
• PCR (blod, milk, tissue)
• qPCR and MLVA-PCR (MultiLocusVariableTandemRepeat Assay)
• Cultivation in cell cultures and animals (level 3 lab.), not
in Denmark
6Why did we start looking for antibodies for
Q fever in cattle in Denmark?
• A Club- 5 meeting in 2003: 
AFSSA, VLA, SVA, DVI, 
CIDC
Until then only animals for•      
export were tested
7Q fever prevalens in blood samples from cattle 2003-2007
600
500
300
400
100
200
0
2003 2004 2005 2006 2007
Positive % 18,0% 35,0% 15,0% 27,5% 16,0%
Positive No. 30 28 28 58 78
Total incl. Positive 164 80 187 211 489
8Other serologic tests in 2003-2004
• All samples were tested for antibodies for: Leptospirosis, 
Neosporosis, BVD and Brucellosis
E ept the Neosporosis all other tests ere negati e• x   :    w  v
• In 2003: 18 % positive for Q fever and halv of them were             
positive for Neosporosis too
• In 2004:  35 % positive for Q fever, 30% was positive for 
Neosporosis 18 % was positive for both Q fever and ,          
Neosporosis 
RESULTS OF DETECTION ANALYSIS FOR Coxiella burnetii in
9
        
FOUR SAMPLES FROM DENMARK, AFSSA 2005-06-10
1.extraction 1.extraction 2.extraction 2.extraction
Samples PCR1 PCR2 PCR1 PCR2
12643-1 - - / + - -
12249 2- - - - -
12555-3 - - - -
12129-5
ALSO STAMP POS
+ + + +
Negative control - - - -
Positive control + + + + 
10
• 742 farms
Prevalence of Q fever  in Denmark 2007
tested in bulk tank milk samples
 
• 429  ( 57%) positive / red
• 276 negative/ blue
• 48 dubious / yellow
11
Using spatial scan statistic we identified a strong geografical trend         
with relatively more positive farms in the western part of the country 
(milk samples 2007).          ( René Bødker & Anna-Bodil Christoffersen, DVT no. 14. 2008)
12Table 1. Samples tested for Q fever (Coxiella burnetii) by serology or FISH in 2009 at the DTU Veterinary Institute.
N = numbers, (pos) = positive samples, C =cases/submissions. Prevalence in bulk milk, cattle: 78,9 %, in individual 
milk, cattle: 43,5 %, in serum, cattle: 19,8 %. Prevalence by FISH test: 7 %.None positive samples from goat/sheep, 
th i lo er an ma s. 
SHEEP/ SHEEP/ SHEEP/
CATTLE CATTLE CATTLE CATTLE GOAT GOAT GOAT PIG DOG
serum bulkmilk individual placenta serum milk placenta serum serum
milk
 
or  fetus
N(pos)C N(pos)C N(pos)C N(pos)C N(pos)C N(pos)C N(pos)C N(pos)C N(pos)C
Purpose
EXPORT 52 (0) 33 - - - 27 (0) 4 - - - -
Diagnostic 111 (22) 69 157 (124) 155 23 (10) 15 14 (1) 14 16 (0) 1 - - - -
Breeding 
stock 5 (0) 2 - - - 2 (0) 1 - - - -
Other 
countries - - - .- - - - - -
Import - - - - 16 (0) 2 - - - -
Method
ELISA 168 (22) 104 157 (124) 155 23 (10) 15 - 61 (0) 8 - - - -
CFT - - - - - - - - -
FISH - - - 14 (1) 14 - - - -
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The study of Q fever in Danish dairy cattle         
herds 2008-2009 (KU-LIFE, Danish Cattle Federation, DTU Vet. Inst.)
• 100 dairy farms were selected randomly, 
and bulk tank milk samples were tested 
by ELISA
• The farmers were interviewed by telefon 
(48 questions) and asked to be tested       
for antibodies against Q-fever, them 
selves and the staff
14
The study of Q fever in Danish dairy cattle herds 
2008-2009 KU-LIFE, Danish Cattle Federation, DTU Vet. Inst.)
• 23 farms selected from the 100 random 
selected farms
• Bulk tank milk tested every month (13 times)
• Individual milk samples tested by ELISA and 
qPCR 3 times from every milking cow 
• Blod samples from selected young and adult 
cattle: testet 3 times in pos farms
• Placenta and abortions investigated in 2 
months
15
Frequency in humans
• Denmark: 
• Until 2005: few cases per year
• In 2006: 47 seropositive humans 
• In 2007: 600 seropositive humans
• Data from projects in 2008: 359 humans tested
- 37% of 87 vets. were positive          
- 2% of     15 insem.were positive 
- 3 % of  163 farmers were positive
- 7 % of    14 hoofcutters were positive
16
Preliminairy results (KU-LIFE, Danish Cattle Federation, DTU Vet. Inst.)
• 2.294 blodsamples, 6.828 individual milk 
samples and 300 bulk tank milk samples were 
tested
• In positiv farms: 
- 15-60 % individuals pos in milk serology       
- 10-25 % individuals pos in blod serology
- 2-95 % individuals pos by qPCR
- few pos milk samples in negative farms      
• Results still on calculation
17
Preliminary results qPCR
1688 milk samples analysed from 12 dairy herds, 
40-96 samples from each herd
Number of PCR-positive samples varies between 2-
95%, 
C 20 38T-range -
18
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• Coxiella burnetii associated placental lesions and infection level in parturient cows
• Mette S Hansen1, Annie Rodolakis2, Denis Cochonneau2, Jens F Agger3, Anna-Bodil 
Christoffersen4, Tim K Jensen4, Jørgen S Agerholm1,3*
• 1 Department of Veterinary Disease Biology, Ridebanevej 3, Faculty of Life Sciences, University 
of Copenhagen, DK-1870 Frederiksberg C, Denmark
• 2 Institut National de la Recherche Agronomique (INRA), UR1282 Infectiologie Animale et Santé 
Publique F-37380 Nouzilly France, ,   
• 3 Department of Large Animal Sciences, Dyrlaegevej 68, Faculty of Life Sciences, University of 
Copenhagen, DK-1870 Frederiksberg C, Denmark
• 4 National Veterinary Institute, Technical University of Denmark, Bülowsvej 27, DK-1790 
Copenhagen V, Denmark
• * Corresponding author: jager@life.ku.dk
• Abstract
Several studies have shown vaginal excretion of Coxiella burnetii in cattle However information•          . ,  
on the interaction between the placenta and the bacterium is very limited. To evaluate this, 
cotyledonary specimens (n = 170) from 19 dairy herds were analysed for C. burnetii by real-time 
PCR targeting the IS1111a and icd genes. Positive cases (n = 90) and a random selection of 
negative cases (n = 20) were examined by histology, immunohistochemistry (IHC) and if the 
infection level was high also by fluorescence in situ hybridization (FISH) PCR results were   ,       .    
compared to bulk tank milk (BMT) antibody levels around the sampling period. Placental infection 
as determined by rt PCR was found in cows irrespectively of the herd BMT antibody level, but the 
frequency of cows having placental infection was generally higher in herds with intermediate or 
high BTM antibody level than in herds with low antibody level. Histological examination revealed a 
range of mostly mild cotyledonary changes It was impossible by blinded examination to identify     .         
infected cases, but statistical analyses showed associations of unknown significance. One case 
had C. burnetii antigens in multiple trophoblasts, but remained negative by FISH. The presence of 
antigens was not associated with inflammation. The study indicates that C. burnetii infection in the 
placenta of parturient cows is rarely associated with inflammation. The lack of lesions may explain 
why bovine Q fever mostly remains clinically unnoticed Furthermore the study confirms that       . ,     
cattle originating from herds with negative BTM antibody levels may shed C. burnetii at calving.
20
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What can we do to get in front of the disease?
•Educate the public on source af infektion ( infection by inhalation still the 
main route ?)
•Source of infektion in calves,lambs,kids: inhalation or neonatal infektion, 
calving, placenta, amniotic fluid, raw milk ?
•Positive farms / pets: Appropriate removal of placenta/ aborted material 
- How?
•Abattoir workers: careful remove and destroy mammary glands, inner 
organs, keep skin wett until salting (Aitken et al 1987) 
•Use only pasteurized milk and milk products- Why do we still eat 
cheese produced from ”lait cru”?  What about meat?
V i ti C l kid l b i l h ( t th )?• acc na on: a ves, s, am s, spec a  uman groups ve s,o ers
•Handling manure – how?
22
Can we do anything intelligent to get in front of this disease?
C S
• What about:
• Instructions for visitors in pos farms?
• Visitors in ZOO ?
• FA T :
• Notifiable disease among animals since 
   
• Instructions for owners of pets (cats, 
dogs, domestic and wild birds)?
• Manure?
2005 in Denmark
• No surveillance program at the moment
• Voluntary interest from vets and cattle   .   
farmers: > 60 % pos cattle farms
• Goat/sheep: les than 100 blood samples 
tested pr year few bulk milk samples  ,    , 
untill now none pos
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Prevalence in dogs and cats.
• German investigation ( Werth 
1987)
• 1127 dogs : 13 %     
seropositive
• 108  cats :   26% 
seropositive 
• Prevalence in 
Denmark unknown
Outbreake of Q fever in the Netherlands
24
      
The Netherlands: 2-20 human cases pr. year until 2006
In 2008: 677 cases, one outbreake
In 2009: > 2000 cases in North Brabrand
D i t d h ia ry goa  an  s eep ma n source 
One special subtype of C. burnetii in nearly all dutch 
cases (MLVA PCR technique)
> 600 dairy goat farms in The Netherlands
several farms have more than 1000 goats
Vaccination of goat and sheep in the Netherlands 2009-2010
25
         
CEVA: phase 1 vaccine (CoxevacR)
- C.burnetii free can be vaccinated
- lower excretion in milk and placenta
- prevent most abortions ( goats /sheep)     
>60.000 not vaccinated pregnant goat/sheep killed in 
the Nederlands  2009/2010
Sufficient vaccine in The Netherlands for all goats and 
sheep in 2010    
Per oral dosis of C burnetii
26
    . 
Experimental in mice (Durand, 1993)
Mice needs 10.000 times more of 
C. burnetii by per oral route than by 
the intraperitonal route  .
Methods: cultivation in eggs and 
serology by CFT
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Q Fever vaccine for humans ( Stephen Graves, Australia)
•Australia is the only country with an approved human vaccine against Q 
fever
•Developed by Marmion and Ormsbee    
•Produced by Australian company “CSL Biotherapies”in  Melbourne
•Licensed for use in 1989
•A formalin-killed phase 1 whole cell Henzerling strain grown in the 
embryonated egg yolk sac   .
•20 years experience and approximately 
• 200.000 doses have been given.
Q Fever Vaccine ( Stephen Graves Australia)
28
     , 
Pre-screening of proposed vaccine recipients 
necessary to prevent adverse reactions to vaccine
Day 1: 
a)Blood taken for C.burnetii serology
b)Intradermal skin test of cell-mediated immunity 
to C burnetii(a “Mantoux”–like test) .   
c)Take medical history of Q Fever
Day 7:
a)No antibodies to C.burnetii
b)No T-cell reaction (no induration) to C.burnetii
c)No history of Q Fever
THEN
d)Vaccinate with 25μg vaccine (0 5ml)    .  
(subcutaneous) x1 dose only.
Day 21: 
a)Patient now immune to Q Fever
b)No need to check for seroconversion
Duration of vaccine protection uncertain but 
lik l t b 10e y o e approx.  years
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Thank you for 
listening
